Contrast-Enhanced Ultrasound With Perflubutane Microbubble Agent: Evaluation of Differentiation of Hepatocellular Carcinoma

Authors:

Abstract
OBJECTIVE. The aim of this study was to evaluate the effectiveness of contrast-enhanced ultrasound with a perflubutane microbubble agent in the assessment of cellular differentiation of hepatocellular carcinoma (HCC).SUBJECTS AND METHODS. Continuous harmonic imaging with a low mechanical index (0.21–0.30) was performed 1, 5, and 10 minutes after IV contrast injection (0.0075 mL/kg). Tumor enhancement was evaluated by both subjective reading and objective intensity analysis based on the signal distribution in the nontumor parenchyma. Tumor vascularity was assessed with CT during hepatic arteriography.RESULTS. Sixty-four patients with 77 histologically proved HCCs (mean greatest dimension, 19.1 ± 5.3 mm)—six poorly differentiated HCCs, 45 moderately differentiated HCCs, and 26 well-differentiated HCCs—were enrolled in this prospective study. Among 64 hyperenhancing lesions on peak enhancement sonograms, four poorly differentiated HCCs and eight moderately differentiated HCCs exhibited washout within 1 minut...

This publication has 35 references indexed in Scilit: